Huawei Technologies Co., Limited

Beigene, Ltd.

Beigene Switzerland Gmbh

Zhiyu Tang

Tong Zhang

Changyou Zhou

Kang Li

Jing Song

Min Wei

Lai Wang

Lusong Luo

Guoliang Zhang

Jun Yang

Xudong Zhang

Hexiang Wang

Bo Ren

Yao Yao

Jingming Yang

Wenxia Hou

Jian Chen

Zhicheng Zhang

An information transmission method is provided, including: A control device obtains a second universal serial bus video class UVC port and a second virtual network port based on configuration of a universal serial bus USB port of the control device. The control device determines address information of a camera device, where a first UVC port and a first virtual network port are configured on the camera device, and the first UVC port and the first virtual network port are obtained based on configuration of a USB port of the camera device. The control device sends the address information to the camera device through a UVC channel, where the UVC channel is established based on the first UVC port and the second UVC port.

Information transmission method and related device

Disclosed herein is a pharmaceutical combination for use in the prevention, delay of progression or treatment of cancer, wherein the pharmaceutical combination exhibits a synergistic efficacy. The pharmaceutical combination comprises a humanized antagonist monoclonal antibody against PD- and a RAF inhibitor. Also disclosed herein is a combination for use in the prevention, delay of progression or treatment of cancer in a subject, comprising administering to the subject a therapeutically effective amount of a humanized antagonist monoclonal antibody against PD-1 and a therapeutically effective amount of a RAF inhibitor.

Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer

Disclosed herein is a method for the prevention, delay of progression or treatment of cancer in a subject, comprising administering to the subject in need thereof a PARP inhibitor, particularly, (R)-2-fluoro-10a-methyl-7,8,9,10,10a,11-hexahydro-5,6,7a,11-tetraazacyclohepta[def]cyclopenta[a]fluoren-4(5H)-one, a sesqui-hydrate thereof, or a pharmaceutically acceptable salt thereof, in combination with an immune checkpoint inhibitor or a chemotherapeutic agent. Also, disclosed a pharmaceutical combination comprising a PARP inhibitor, particularly, (R)-2-fluoro-10a-methyl-7,8,9,10,10a,11-hexahydro-5,6,7a,11-tetraazacyclohepta[def]cyclopenta[a]fluoren-4(5H)-one, a sesqui-hydrate thereof, or a pharmaceutically acceptable salt thereof, in combination with an immune checkpoint inhibitor, or a chemotherapeutic agent and the use thereof.

Treatment cancers using a combination comprising PARP inhibitors

A method for establishing a neighbor relationship, where corresponding authentication information is added to packets that are sent from a first network device and a second network device to each other. The first network device sends a hello packet to the second network device. The second network device receives the hello packet, performs authentication, and responds to the hello packet using an extended unidirectional link (UDL) link state packet (LSP) when the authentication succeeds. The first network device receives the extended UDL LSP, and performs authentication. When an authentication result includes that both the first network device and the second network device enable authentication and the authentication succeeds, a neighbor relationship between the first network device and the second network device may be established.

Neighbor establishment method and system, and device

Growing community of inventors

Beijing, China

Zhiyu Tang